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pPleurectomy-decortication (P/D) was first popularized inthe mid 1950s as a surgical method for treating entrapped
lung that developed as a complication of tuberculous empyema.
P/D evolved as a treatment for a variety of lung pathologies
including other infectious empyemas, effusive metastatic dis-
ease, and pleural metastases. As diffusemalignant pleural meso-
thelioma (MPM) came to prominence in 1960, when Wagner
and coworkers described MPM in asbestos mine workers from
South Africa,1 P/D was one method adapted and utilized for
treating MPM. A rare disease with an incidence of just under 1
per 100,000 in the United States, cases of MPM have increased
since the 1970s with an estimated 2000 to 3000 new diagnoses
in America each year.2 Today, MPM remains a lethal cancer
without consensus regarding optimal staging and treatment. In
particular, the role of surgical resection in MPM and, specifi-
cally, the choice of extrapleural pneumonectomy (EPP) versus
P/D, remains highly controversial.
Definitions
P/D is an attempt to remove all gross disease without remov-
ing the underlying lung and involves resection of the parietal
pleura, visceral pleura, the pericardium, and, in roughly 50%
of patients, the diaphragm. Macroscopic evidence of involve-
ment of the pericardium requires resection and reconstruc-
tion; however, diaphragmatic disease can often be success-
fully stripped from the surface of the diaphragm without
formal resection and reconstruction.
Indications and Contraindications
MPMwas universally thought to be fatal in the era before effec-
tive systemic therapy. Surgery was primarily used for diagnostic
or palliative purposes. In 1976, Butchart and colleagues re-
ported their experience with EPP for MPM and documented
durable long-term survival, yet a 33% operative mortality.3 Re-
nements in patient selection and perioperative care substan-
ially decreased mortality rates. Contemporary series report
ortality as low as 3.4%4 and 5.2%,5 illustrating that high-
volume centers could performEPP safely. Nonetheless, the high
mortality and morbidity associated with EPP, and the well-
known complications of pneumonectomy, led some surgeons
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there is no evidence showing superiority of EPP over P/D.6 Re-
ardless of technique, certain fundamentals hold true: surgery is
key component in the treatment of MPM and achieving a
acroscopic complete resection is the goal. Indications support-
ng P/D over EPP can be related to either patient or tumor char-
cteristics. In patientswith insufficient cardiopulmonary reserve
or pneumonectomy, a postoperative predicted forced expira-
ory volume in one second or a diffusing capacity of the lung for
arbon monoxide of less than 40%, or a left ventricular ejection
raction of less than 45%, P/D is clearly indicated. In early stage
isease, confined to the parietal pleura (Butchart I, IMIGT1a) or
onfined to parietal and visceral pleura without involvement of
nderlying lung parenchyma (IMIG T1b), P/D provides clear-
nce of disease without the additional morbidity or mortality of
pneumonectomy.
Inpatientswith confluent sheets of tumor involving the entire
ung and obliterating the pleural space, P/D is unfeasible and
PP should be considered. Computed tomographic (CT) scans
ay provide preoperative evidence of this level of tumor in-
olvement, but often this decision is made intraoperatively.
PM is a disease where a true R0 resection is impossible and
urgical therapy provides removal of gross tumor as a founda-
ion for adjuvant therapy. With this perspective, P/D may limit
djuvant therapy by limiting the dose of radiation used in the
ostoperative hemithorax. However, with newer methods of
adiation administration such as intensity modulated radiation
herapy and encouraging results with systemic chemotherapy,
esidual lung parenchyma left after P/D may not alter adjuvant
herapy as much as previously thought and may protect the
atient from the morbidity of a pneumonectomy.
Preoperative Evaluation
Imaging of the chest andupper abdomenwithCT ismandatory.
If chest wall or neurovascular invasion is suspected,MRImay be
helpful in preoperative planning. Positron emission tomogra-
phy/CT is done to screen for distant metastatic disease and the
standard uptake value can be used to predict the presence of N2
lymphatic spread.7 Although N2 disease does impart a worse
rognosis in MPM, it should not be used as an absolute criteria
enying surgical resection. Therefore, there is no absolute indi-
ation for preoperative mediastinoscopy. Ventilation/perfusion
cans arehelpful in caseswherepulmonary function tests (PFTs)
re questionable or the extent of pleural disease significantly
lters the patient’s ability to perform for the PFTs and a more
ccurate assessment of lung function is needed. Patients with
ostoperative predicted values of greater than 40% are consid-
red acceptable for either EPP or P/D.
Technique of pleurectomy and decortication 295Operative TechniqueFigure 1 Positioning and approach: Following the induction of general anesthesia, a double-lumen endotracheal tube is used
to facilitate single-lung ventilation. An arterial line and central venous line are also used to aid in arterial and venous pressure
monitoring as blood loss is often significant. Thepatient is placed in the lateral decubitus position.An extendedposterolateral
thoracotomy incision, extending down toward the costal margin over the 10th rib and posteriorly beyond the tip of the
scapula, ismade. At first, amore limited incision, such as a standard posterolateral thoracotomy incision, can be used to start
the procedure. After intrathoracic assessment of respectability, the incision can be extended anteriorly as mentioned above.
296 A.J. Kaufman and R.M. FloresFigure 2 Exposure: The incision is brought down over the sixth rib and the periosteum is elevated off the rib superiorly
and inferiorly. A periosteal elevator is used to separate the rib for the surrounding soft tissue. A Bethune rib cutter is
used to divide the rib anteriorly and posteriorly and the rib is removed. Dissection between the endothoracic fascia and
the parietal pleura is begun. Allis clamps placed on the endothoracic fascia elevating the fascia away from the pleura
allows for easier dissection in the plane between the 2 layers. Once an area large enough for a finger is created, blunt
dissection of the tumor laden pleura can be easily undertaken with a finger.
Technique of pleurectomy and decortication 297Figure 3 Dissection of the extrapleural plane: The plane is then developed in a cephalad direction toward the apex from
the posterolateral direction. Both blunt and sharp dissection are used with sharp dissection reserved mainly for areas
of dense adhesions. The apex is usually relatively free of tumor compared with the diaphragmatic surface, and
dissection in this direction first will make exposure and inferior dissection easier. The placement of 2 Finnechetto
retractors, 1 anteriorly and the other posteriorly, greatly enhances the visualization of the thoracic cavity. As the
dissection moves anteriorly, injury to the internal mammary vessels must be avoided. Blunt dissection with sponge
sticks can effectively separate the pleura from the anterior chest wall close to the mammary vessels but sharp dissection
is recommended once the vessels are encountered. As the area of dissection increases, previous areas of dissection are
packed with laparotomy pads for hemostasis.
298 A.J. Kaufman and R.M. FloresFigure 4 Dissecting the apex: The subclavian vessels
lie at the apex of the thoracic cavity. As the dissec-
tion progresses toward the apex, great care must be
used in dissection around the subclavian vessels. As
the dissection proceeds toward the mediastinum,
the azygous vein and superior vena cava are ap-
proached carefully. Once the upper portion of the
lung is completely mobilized from the chest wall,
the superior and posterior hilar structures are well
exposed. (A) The aorta and arch vessels must be
identified and carefully dissected. Injury to the
phrenic nerve and recurrent laryngeal nerve must
also be avoided. (B) After the right upper lobe and
right mainstem bronchus are exposed, dissection of
the esophagus is begun. A nasogastric tube is help-
ful in palpating and identifying the esophagus. The
superior vena cava is gently dissected off the speci-
men and the dissection continues to the posterior
aspect of the pericardium. The vagus and phrenic
nerves again are identified and protected. a.  ar-
tery; n.  nerve; SVC  superior vena cava; v. 
vein.
Technique of pleurectomy and decortication 299Figure 5 Elevation of the parietal pleura off the diaphragm: The burden of tumor at the level of the diaphragm will
determine if resection is necessary. If the parietal pleura peels easily off the diaphragm, the diaphragm can remain
intact. (Reprinted with permission from Wolf AS, Daniel J, Sugarbaker DJ: Surgical techniques for multimodality
treatment of malignant pleural mesothelioma: extraplerual pneumonectomy and pleurectomy/decortication. Semin
Thorac Cardiovasc Surg 21:132-148, 2009.)
300 A.J. Kaufman and R.M. FloresFigure 6 If there is substantial diaphragmatic invasion, the diaphragm is resected bluntly by avulsing off the chest wall.
The diaphragmatic muscle attachments to the chest wall are manually separated with a fingertip as done with EPP. Care
is taken to dissect the peritoneum off the undersurface of the diaphragm muscle. The diaphragm is grasped in an Allis
clamp or Babcock clamp and retracted upward. The peritoneum is gently dissected off the undersurface with a sponge
stick. At the esophageal hiatus the inferior vena cava must be identified and great care used in the dissection of the
diaphragm off the inferior vena cava. (Reprinted with permission from Wolf AS, Daniel J, Sugarbaker DJ: Surgical
techniques for multimodality treatment of malignant pleural mesothelioma: extraplerual pneumonectomy and pleu-
rectomy/decortication. Semin Thorac Cardiovasc Surg 21:132-148, 2009.)
Technique of pleurectomy and decortication 301Figure 7 Decortication: Once the pari-
etal pleura has been freed in all areas,
attention is shifted toward separating
the visceral pleura from the underly-
ing lung parenchyma. (A) Using a
scalpel, an incision is made in the tu-
mor overlying the area of the sixth rib
and brought down to healthy lung tis-
sue but avoiding injury to the paren-
chyma. A plane is created between the
visceral pleura, which is adherent to
the tumor, and the lung parenchyma
with gentle blunt dissection with a
peanut sponge (B). The plane of dis-
section is brought superiorly over the
apex and then inferiorly. (Reprinted
with permission fromWolf AS, Daniel
J, Sugarbaker DJ: Surgical techniques
for multimodality treatment of mal-
ignant pleural mesothelioma: extra-
plerual pneumonectomy and pleurec-
tomy/decortication. Semin Thorac
Cardiovasc Surg 21:132-148, 2009.)
302 A.J. Kaufman and R.M. FloresFigure 8 The incision in the pleura can be extended anteriorly toward the hilum. The lung parenchyma is then pulled
out of the tumor/pleural cap. (Reprinted with permission from Wolf AS, Daniel J, Sugarbaker DJ: Surgical techniques
for multimodality treatment of malignant pleural mesothelioma: extraplerual pneumonectomy and pleurectomy/
decortication. Semin Thorac Cardiovasc Surg 21:132-148, 2009.)
Technique of pleurectomy and decortication 303Figure 9 Repair of the diaphragm: After resection of the diaphragm, care must be taken to repair the diaphragm by
attaching the diaphragmatic patch to the pericardium. In addition, the patch must be pulled taut to protect the residual
lung from loss of domain and atelectasis caused by upward motion of the abdominal organs. On the right, a double-
layer Dexon mesh (Covidien, Norwalk, CT) is adequate. On the left, 2-mm-thickness Gore-Tex (W.L. Gore &
Associates, Inc, Flagstaff, AZ) is used because a thicker, nonabsorbable material is needed to prevent herniation of
abdominal contents. The prosthesis is secured laterally by sutures placed around the ribs through the soft tissue of the
chest wall. (Reprinted with permission from Wolf AS, Daniel J, Sugarbaker DJ: Surgical techniques for multimodality
treatment of malignant pleural mesothelioma: extraplerual pneumonectomy and pleurectomy/decortication. Semin
Thorac Cardiovasc Surg 21:132-148, 2009.)
304 A.J. Kaufman and R.M. FloresFigure 10 If the diaphragm is largely intact, it can be closed primarily by plication. Nonabsorbable sutures, such as
0-Prolene sutures, are used to imbricate the diaphragm to itself. If the pericardium has been resected, Dexon mesh is
used for reconstruction.
Technique of pleurectomy and decortication 305Figure 11 Attention is now turned to obtaining hemostasis. An argon beam coagulator is helpful in controlling diffuse
chest wall bleeding. Another, oftenmore effective device, is the Aquamantys System bipolar coagulator (Salient Surgical
Technologies, Portsmouth, NH). Three 28-French chest tubes are then placed: 1 anterior, 1 posterior, and 1 right-
angled. The right-angled tube is placed from the most anterior incision so it rests along the diaphragm toward the most
dependent area of the chest. Evacuation of blood and control of air leaks can be accomplished and full expansion of the
lung is expected. Air leaks tend to seal within 72 hours if the lung is fully expanded. (Reprinted with permission from
Wolf AS, Daniel J, Sugarbaker DJ: Surgical techniques for multimodality treatment of malignant pleural mesothelioma:
extraplerual pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21:132-148, 2009.)
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P/D is a safe procedure with mortality limited to approxi-
mately 1 to 4%. The most common postoperative complica-
tion is prolonged air leak (air leak lasting more than 7 days),
which occurs in upward of 10% of cases. Continued chest
tube drainage is sufficient in a majority of cases as the air
leaks will seal over time. Pleurodesis is reserved for air leaks
that fail simple chest tube drainage and good expansion of the
lung parenchyma is observed on chest x-ray. Rarely, contin-
ued air leaks are managed with a BD Bard-Parker Heimlich
Valve (BD, Franklin Lakes, NJ). In these cases, all but 1 chest
tube is removed after sequential clamping and serial chest
x-rays document adequate lung expansion. Median survival
time ranges from 9 to 20 months. The literature shows that
surgery alone is insufficient therapy and results in rapid re-
lapse of disease.8 Suboptimal cytoreduction is believed to be
he cause. Irrespective of procedure, EPP or P/D, a complete
0 resection is impossible because microscopic disease is
nvariably left behind. Therefore, most treatment regimens
ave focused on multimodality approaches combining a sur-
ical procedure for cytoreduction with chemotherapy and
adiation in a multimodality setting. The majority of recent
tudies have described either EPP or P/D in combination with
eoadjuvant or adjuvant chemotherapy, intrathoracic che-
otherapy, adjuvant external beam radiotherapy or intensity
odulated radiation therapy, intraoperative radiotherapy, or
rachytherapy. Due to small sample sizes and comparatively
eterogeneous groups, a consensus on treatment strategies
nd conclusions regarding optimal therapy remain lacking.
In the largest study to date, Flores and coworkers analyzed
63 MPM patients from 3 different institutions and com-
ared overall 5-year survival. A total of 385 patients were
dentified who underwent EPP and 278 patients who under-
ent P/D. Of these patients, a statistically significant number
f early stage (I-II) patients favored P/D, whereas a statisti-
ally significant number of patients favored EPP due toounger age and having received multimodality therapy. In
nivariate analysis, P/D was associated with a significantly
etter median survival than EPP (P  0.001). However, in a
ultivariate analysis by a Cox proportional hazard model
hat controlled for histology, stage, gender, and multimodal-
ty therapy, EPP had only a modestly higher hazard ratio of
.4 when compared with P/D. Of note, operative mortality
as 7% in the EPP group and 4% in the P/D group with a
igher proportion of EPP patients experiencing serious respi-
atory complications (10%) compared with the P/D cohort
6.4%).6 Until a randomized controlled trial is completed,
current therapy remains controversial with the choice of P/D
or EPP directed by a combination of disease characteristics,
patient characteristics, and surgeon discretion.
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